Jennifer Lehrman

Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target

Laura M. Walker, Sanjay Phogat, Po-Ying Chan-Hui et al. · Science · 2009 · 1.7K citations

Life Sciences, Immunology, Infectious Diseases +17

Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm

Melissa Simek, Wasima Rida, Frances Priddy et al. · Journal of Virology · 2009 · 581 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

A Phase 1 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Subtype C Adeno-Associated Virus Vaccine

Sanjay Mehendale, Jan van Lunzen, Nathan Clumeck et al. · AIDS Research and Human Retroviruses · 2008 · 55 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Vaccine Based on Adeno-Associated Virus

Eftyhia Vardas, Pontiano Kaleebu, Linda‐Gail Bekker et al. · AIDS Research and Human Retroviruses · 2010 · 48 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults

Juliet Mpendo, Gaudensia Mutua, Julien Nyombayire et al. · PLoS ONE · 2015 · 44 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17